12.02.24 -- Translating Hidden Gems Into Medicines

Learn more about the potential of allogeneic cell therapies to combine the efficacy of personalized medicine with the scalability, accessibility, and uniformity of traditional off-the-shelf therapeutics.

Explore how tools streamline the development of cell-based therapies by optimizing processes, reducing costs, and accelerating manufacturing scalability. 

By employing comprehensive data analysis solutions, pharmaceutical companies can enhance their competitive intelligence and make better research, communications, and business decisions.

Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

By leveraging proprietary E. coli strains with extensive genetic modifications, biopharma companies can overcome challenges and accelerate the development of innovative protein-based therapies.